Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$88.81 -1.39 (-1.55%)
As of: Oct 21, 2026 · 2:22 PM EDT

Rhythm Pharmaceuticals (RYTM) Other financing activities (2026)

Updated

Rhythm Pharmaceuticals (RYTM) recorded Other financing activities of $1.26 million in Q2 2026, down 85.1% from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Other financing activities (2026) Analysis & Trends

On a TTM basis, Rhythm Pharmaceuticals' Other financing activities came in at $9.72 million as of Jun 30, 2026; for FY2024, it came in at $8.9 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,135.43 Bn 1,104.02 Bn 19.71 Bn
2 Johnson & Johnson 616.54 Bn 535.06 Bn 17.26 Bn
3 AbbVie 501.55 Bn 474.66 Bn 12.70 Bn
4 Merck 367.19 Bn 321.57 Bn 12.21 Bn
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn
6 Astrazeneca 261.40 Bn 235.09 Bn 12.86 Bn
7 Amgen 236.18 Bn 191.58 Bn 7.24 Bn
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn
10 Rhythm Pharmaceuticals 6.10 Bn 4.97 Bn 62.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.26 Mn
Mar 31, 2026 -8.46 Mn
API Access

Rhythm Pharmaceuticals Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=RYTM&period=max&api_key=YOUR_API_KEY